SALVATORI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 2.091
EU - Europa 994
AS - Asia 614
SA - Sud America 11
OC - Oceania 2
AF - Africa 1
Totale 3.713
Nazione #
US - Stati Uniti d'America 2.090
CN - Cina 399
IT - Italia 223
PL - Polonia 198
UA - Ucraina 168
DE - Germania 153
TR - Turchia 82
SG - Singapore 80
GB - Regno Unito 74
SE - Svezia 57
FI - Finlandia 39
FR - Francia 27
IR - Iran 14
BE - Belgio 13
ID - Indonesia 13
CZ - Repubblica Ceca 10
BR - Brasile 9
RU - Federazione Russa 9
RO - Romania 8
NL - Olanda 7
IN - India 5
MY - Malesia 4
VN - Vietnam 4
CH - Svizzera 3
ES - Italia 3
IQ - Iraq 3
TW - Taiwan 3
AU - Australia 2
KR - Corea 2
AR - Argentina 1
CA - Canada 1
CO - Colombia 1
GE - Georgia 1
IE - Irlanda 1
JP - Giappone 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
PK - Pakistan 1
TN - Tunisia 1
Totale 3.713
Città #
Woodbridge 290
Chandler 219
Jacksonville 204
Warsaw 198
Houston 162
Beijing 148
Ann Arbor 138
Fairfield 137
Ashburn 124
Wilmington 91
Nanjing 69
Ferrara 59
Izmir 53
Bologna 50
Seattle 49
Princeton 46
Singapore 44
Addison 41
New York 41
Cambridge 40
Shanghai 36
Boardman 33
Milan 31
Bremen 28
Shenyang 20
Redwood City 18
Auburn Hills 16
Falls Church 14
Hebei 14
San Diego 14
Dearborn 13
Jakarta 13
Nanchang 13
Brussels 12
Jiaxing 12
Brno 10
Changsha 10
Los Angeles 10
Tianjin 10
Munich 9
San Jose 9
Mountain View 8
Guangzhou 7
Leiden 7
Hefei 6
Jinan 6
Lanzhou 6
Ningbo 6
Zhengzhou 6
Cattolica 5
Des Moines 5
Cagliari 4
Dong Ket 4
Fuzhou 4
Indiana 4
Kunming 4
Leawood 4
Napoli 4
Norwalk 4
Orange 4
Padova 4
Ravenna 4
Alcamo 3
Hangzhou 3
Kundan 3
Pars 3
Taipei 3
Turin 3
Ankara 2
Ardabil 2
Ashwell 2
Campobasso 2
Castello Di Fiemme 2
Chengdu 2
Custom House 2
Edinburgh 2
Kansas City 2
Kilburn 2
Kirkuk 2
Kota Bharu 2
Kuala Lumpur 2
London 2
Modena 2
Rome 2
San Mateo 2
Southwark 2
Sydney 2
Anna 1
Augusta 1
Barcelona 1
Beirut 1
Bogotá 1
Bovisio Masciago 1
Buenos Aires 1
Carini 1
Carnago 1
Cartura 1
Changchun 1
Chiswick 1
Clifton 1
Totale 2.723
Nome #
Strategies for the adult haemoglobin (HbA) production in β0-thalassemia patients 169
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 164
SPR-based non-invasive prenatal testing for fetal sex determination 136
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 135
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 134
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 132
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 114
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 111
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 109
null 107
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 103
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients. 97
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 94
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 93
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 90
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 89
null 85
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 83
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 81
Gene therapy combined with HbF induction in beta-thalassemia 80
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 79
Development and molecular characterization of transgenic mice for beta-thalassemia 76
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 75
null 75
Produzione di emoglobina in cellule Eritroidi da pazienti con Beta Talassemia alterando processi biomolecolari in grado di regolare l'espressione dei geni per le globine. 74
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 69
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 69
null 69
PNA-mediated alteration of mRNA splicing 66
Gene therapy and fetal hemoglobin induction 65
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 65
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 62
Cellular biosensors for the identification of fetal hemoglobin inducers 61
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 61
Generation and molecular characterization of a transgenic mouse line carrying a mutated human °39 thalassemia -globin gene 59
Readthrough of the premature stop codon beta039-thalassemia 58
Production of a cellular model for the screening of inducers of fetal haemoglobin 57
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 56
Control of Erwinia amylovora Growth by Moringa oleifera Leaf Extracts: In Vitro and in Planta Effects 50
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 47
null 40
UPF1 silenced cellular model systems for screening of read-through agents active on β039 thalassemia point mutation 39
Effects of Moringa oleifera Leaf Extracts on Xanthomonas campestris pv. campestris 37
PLCB3 Loss of Function Reduces Pseudomonas aeruginosa-Dependent IL-8 Release in Cystic Fibrosis 36
Screening Readthrough Compounds to Suppress Nonsense Mutations: Possible Application to β-Thalassemia 36
Suppressing gain-of-function proteins via CRISPR/Cas9 system in SCA1 cells 30
Evidences for miRNA regulation of BCL11A gene expression 19
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 16
Epigenetic role of LINE-1 methylation and key genes in pregnancy maintenance 14
LINE-1 global DNA methylation, iron homeostasis genes, sex and age in sudden sensorineural hearing loss (SSNHL) 13
Peptide nucleic acids targeting the murine beta-globin mRNAs selectively inhibit hemoglobin production in Murine Erythroleukemia (MEL) cells. 13
Tobramycin is a suppressor of premature termination codons. 11
miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach 6
Totale 3.809
Categoria #
all - tutte 15.588
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 370
Totale 15.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020629 124 17 21 70 31 70 46 53 42 102 34 19
2020/2021614 53 41 24 42 47 58 22 56 25 66 124 56
2021/2022469 45 39 13 15 29 23 22 18 15 44 39 167
2022/2023496 57 53 11 63 94 63 28 40 41 9 21 16
2023/2024385 22 40 19 7 32 64 56 25 5 18 23 74
2024/202552 52 0 0 0 0 0 0 0 0 0 0 0
Totale 3.809